Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD4
|
ENSG00000141646.14 | SMAD family member 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD4 | hg38_v1_chr18_+_51030100_51030270 | -0.12 | 5.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22720615 | 13.30 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr14_-_105743032 | 10.33 |
ENST00000390548.6
ENST00000390549.6 ENST00000390542.6 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr2_-_88857582 | 8.34 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr9_-_34691204 | 8.23 |
ENST00000378800.3
ENST00000311925.7 |
CCL19
|
C-C motif chemokine ligand 19 |
chr22_+_22811737 | 7.83 |
ENST00000390315.3
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr11_+_117199363 | 7.38 |
ENST00000392951.9
ENST00000525531.5 ENST00000278968.10 |
TAGLN
|
transgelin |
chr2_+_89862438 | 7.16 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr22_+_22431949 | 6.75 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr14_-_106335613 | 6.43 |
ENST00000603660.1
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr22_+_22792485 | 5.97 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr2_+_88885397 | 5.92 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr14_-_105771405 | 5.91 |
ENST00000641136.1
ENST00000390551.6 |
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr19_-_45602153 | 5.74 |
ENST00000544371.1
ENST00000323040.5 |
OPA3
GPR4
|
outer mitochondrial membrane lipid metabolism regulator OPA3 G protein-coupled receptor 4 |
chr10_+_79610932 | 5.69 |
ENST00000428376.6
ENST00000398636.8 ENST00000419470.6 ENST00000429958.5 |
SFTPA1
|
surfactant protein A1 |
chr22_+_22895368 | 5.36 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 |
chr19_-_15464525 | 5.12 |
ENST00000343625.12
|
RASAL3
|
RAS protein activator like 3 |
chr14_-_106211453 | 5.12 |
ENST00000390606.3
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
chr22_+_22322452 | 5.08 |
ENST00000390290.3
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr19_+_11538767 | 5.07 |
ENST00000592923.5
ENST00000535659.6 |
CNN1
|
calponin 1 |
chr19_+_11538844 | 4.98 |
ENST00000252456.7
|
CNN1
|
calponin 1 |
chr22_+_22697789 | 4.93 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr14_-_106422175 | 4.80 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr22_+_22758698 | 4.75 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr22_+_22686724 | 4.74 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr22_+_22668286 | 4.68 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr11_-_118342691 | 4.60 |
ENST00000300692.9
|
CD3D
|
CD3d molecule |
chrX_+_153494970 | 4.52 |
ENST00000331595.9
ENST00000431891.1 |
BGN
|
biglycan |
chr2_+_90114838 | 4.49 |
ENST00000417279.3
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 |
chr2_-_88966767 | 4.37 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr22_+_22380766 | 4.22 |
ENST00000390297.3
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr17_+_42851167 | 4.21 |
ENST00000613571.1
ENST00000308423.7 |
AOC3
|
amine oxidase copper containing 3 |
chr22_+_22904850 | 4.16 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr15_+_49423233 | 4.14 |
ENST00000560270.1
ENST00000267843.9 ENST00000560979.1 |
FGF7
|
fibroblast growth factor 7 |
chr14_-_105940235 | 4.11 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr19_-_17847962 | 4.10 |
ENST00000458235.7
ENST00000534444.1 |
JAK3
|
Janus kinase 3 |
chr2_-_157439403 | 4.05 |
ENST00000418920.5
|
CYTIP
|
cytohesin 1 interacting protein |
chr12_-_14950606 | 3.95 |
ENST00000536592.5
|
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr1_-_30757767 | 3.94 |
ENST00000294507.4
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr8_+_103371490 | 3.83 |
ENST00000330295.10
ENST00000415886.2 |
CTHRC1
|
collagen triple helix repeat containing 1 |
chr15_-_21742799 | 3.83 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chr22_-_24245059 | 3.81 |
ENST00000398292.3
ENST00000263112.11 ENST00000327365.10 ENST00000424217.1 |
GGT5
|
gamma-glutamyltransferase 5 |
chr10_+_80132722 | 3.77 |
ENST00000372263.4
|
PLAC9
|
placenta associated 9 |
chr13_-_39603123 | 3.73 |
ENST00000379589.4
|
LHFPL6
|
LHFPL tetraspan subfamily member 6 |
chr1_-_161199044 | 3.71 |
ENST00000367995.3
ENST00000367996.6 |
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif 4 |
chr15_+_80779343 | 3.70 |
ENST00000220244.7
ENST00000394685.8 ENST00000356249.9 |
CEMIP
|
cell migration inducing hyaluronidase 1 |
chr1_+_27342014 | 3.68 |
ENST00000618673.4
ENST00000318074.9 ENST00000616558.5 |
SYTL1
|
synaptotagmin like 1 |
chr20_+_32010429 | 3.67 |
ENST00000452892.3
ENST00000262659.12 |
CCM2L
|
CCM2 like scaffold protein |
chr1_+_26159071 | 3.64 |
ENST00000374268.5
|
FAM110D
|
family with sequence similarity 110 member D |
chr22_+_22195753 | 3.61 |
ENST00000390285.4
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr2_-_89213917 | 3.51 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr8_-_119592954 | 3.48 |
ENST00000522167.5
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr14_-_105845677 | 3.46 |
ENST00000390556.6
|
IGHD
|
immunoglobulin heavy constant delta |
chr14_-_106771020 | 3.46 |
ENST00000617374.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr10_-_72088972 | 3.45 |
ENST00000317376.8
ENST00000412663.5 |
SPOCK2
|
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 |
chr19_+_49335396 | 3.41 |
ENST00000598095.5
ENST00000426897.6 ENST00000323906.9 ENST00000535669.6 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr11_-_118342616 | 3.40 |
ENST00000392884.2
|
CD3D
|
CD3d molecule |
chr11_-_118342645 | 3.40 |
ENST00000529594.5
|
CD3D
|
CD3d molecule |
chr14_-_106038355 | 3.39 |
ENST00000390597.3
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr10_+_80132591 | 3.36 |
ENST00000372267.6
|
PLAC9
|
placenta associated 9 |
chr1_-_160711803 | 3.36 |
ENST00000368045.3
ENST00000368046.8 ENST00000613788.1 |
CD48
|
CD48 molecule |
chr17_+_7407838 | 3.34 |
ENST00000302926.7
|
NLGN2
|
neuroligin 2 |
chr7_+_94394886 | 3.31 |
ENST00000297268.11
ENST00000620463.1 |
COL1A2
|
collagen type I alpha 2 chain |
chr2_-_241858882 | 3.27 |
ENST00000334409.10
|
PDCD1
|
programmed cell death 1 |
chr22_+_22375984 | 3.19 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr9_-_110579880 | 3.16 |
ENST00000401783.6
ENST00000374461.1 |
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr17_-_63700100 | 3.15 |
ENST00000578993.5
ENST00000259006.8 ENST00000583211.5 |
LIMD2
|
LIM domain containing 2 |
chr1_+_32274111 | 3.14 |
ENST00000619559.4
ENST00000461712.6 ENST00000373562.7 ENST00000477031.6 ENST00000373557.6 ENST00000333070.4 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
chr11_+_43942627 | 3.12 |
ENST00000617612.3
|
C11orf96
|
chromosome 11 open reading frame 96 |
chr8_+_103372388 | 3.11 |
ENST00000520337.1
|
CTHRC1
|
collagen triple helix repeat containing 1 |
chr5_-_151686953 | 3.11 |
ENST00000538026.5
ENST00000522348.1 ENST00000521569.1 |
SPARC
|
secreted protein acidic and cysteine rich |
chr19_+_11539894 | 3.10 |
ENST00000586059.5
|
CNN1
|
calponin 1 |
chr9_-_110579704 | 3.09 |
ENST00000374469.6
|
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr1_-_206921987 | 3.09 |
ENST00000530505.1
ENST00000442471.4 |
FCMR
|
Fc fragment of IgM receptor |
chr9_+_133534807 | 3.09 |
ENST00000393060.1
|
ADAMTSL2
|
ADAMTS like 2 |
chr6_+_32741382 | 3.07 |
ENST00000374940.4
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr8_-_6978634 | 3.03 |
ENST00000382679.2
|
DEFA1
|
defensin alpha 1 |
chr22_+_22327298 | 3.03 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr3_+_52495330 | 3.02 |
ENST00000321725.10
|
STAB1
|
stabilin 1 |
chr1_-_169630115 | 3.02 |
ENST00000263686.11
ENST00000367788.6 |
SELP
|
selectin P |
chr10_+_73911104 | 3.00 |
ENST00000446342.5
ENST00000372764.4 |
PLAU
|
plasminogen activator, urokinase |
chr10_+_86958557 | 2.90 |
ENST00000372017.4
ENST00000348795.8 |
SNCG
|
synuclein gamma |
chr5_-_122078249 | 2.88 |
ENST00000231004.5
|
LOX
|
lysyl oxidase |
chr10_-_88952763 | 2.88 |
ENST00000224784.10
|
ACTA2
|
actin alpha 2, smooth muscle |
chr19_+_45668191 | 2.87 |
ENST00000652180.1
ENST00000590918.6 ENST00000263281.7 ENST00000304207.12 |
GIPR
|
gastric inhibitory polypeptide receptor |
chr10_-_72088533 | 2.87 |
ENST00000373109.7
|
SPOCK2
|
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 |
chr12_-_14951106 | 2.85 |
ENST00000541644.5
ENST00000545895.5 |
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr1_-_58784035 | 2.84 |
ENST00000371222.4
|
JUN
|
Jun proto-oncogene, AP-1 transcription factor subunit |
chr6_-_32763466 | 2.81 |
ENST00000427449.1
ENST00000411527.5 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr17_-_36017953 | 2.78 |
ENST00000612516.4
ENST00000615050.2 |
CCL23
|
C-C motif chemokine ligand 23 |
chr6_+_116616467 | 2.76 |
ENST00000229554.10
ENST00000368581.8 ENST00000368580.4 |
RSPH4A
|
radial spoke head component 4A |
chr11_-_76669985 | 2.76 |
ENST00000407242.6
ENST00000421973.1 |
LRRC32
|
leucine rich repeat containing 32 |
chr1_-_206921867 | 2.76 |
ENST00000628511.2
ENST00000367091.8 |
FCMR
|
Fc fragment of IgM receptor |
chr17_-_19387170 | 2.75 |
ENST00000395592.6
ENST00000299610.5 |
MFAP4
|
microfibril associated protein 4 |
chr1_+_21812265 | 2.74 |
ENST00000344642.7
ENST00000543870.1 |
LDLRAD2
|
low density lipoprotein receptor class A domain containing 2 |
chr5_+_151025343 | 2.74 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 |
chr14_-_106675544 | 2.73 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr22_+_24181476 | 2.70 |
ENST00000358321.4
|
SUSD2
|
sushi domain containing 2 |
chr1_+_159171607 | 2.70 |
ENST00000368124.8
ENST00000368125.9 ENST00000416746.1 |
CADM3
|
cell adhesion molecule 3 |
chr6_+_33080445 | 2.68 |
ENST00000428835.5
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chrX_-_48470243 | 2.67 |
ENST00000429543.2
ENST00000620913.5 |
SLC38A5
|
solute carrier family 38 member 5 |
chr2_+_90234809 | 2.65 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr6_-_169253835 | 2.61 |
ENST00000649844.1
ENST00000617924.6 |
THBS2
|
thrombospondin 2 |
chr19_+_735026 | 2.59 |
ENST00000592155.5
ENST00000590161.2 |
PALM
|
paralemmin |
chr6_+_96563117 | 2.59 |
ENST00000450218.6
|
FHL5
|
four and a half LIM domains 5 |
chr2_-_88861563 | 2.58 |
ENST00000624935.3
ENST00000390241.3 |
ENSG00000240040.6
IGKJ2
|
novel transcript immunoglobulin kappa joining 2 |
chr14_-_106791226 | 2.57 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr9_+_109780292 | 2.55 |
ENST00000374530.7
|
PALM2AKAP2
|
PALM2 and AKAP2 fusion |
chr1_-_169630076 | 2.55 |
ENST00000367786.6
ENST00000458599.6 ENST00000367795.2 |
SELP
|
selectin P |
chr12_-_9760893 | 2.54 |
ENST00000228434.7
ENST00000536709.1 |
CD69
|
CD69 molecule |
chr11_+_61102465 | 2.53 |
ENST00000347785.8
ENST00000544014.1 |
CD5
|
CD5 molecule |
chr2_-_157488829 | 2.52 |
ENST00000435117.1
ENST00000439355.5 |
CYTIP
|
cytohesin 1 interacting protein |
chr8_+_22161788 | 2.52 |
ENST00000521315.5
ENST00000437090.6 ENST00000679463.1 ENST00000520605.5 ENST00000522109.5 ENST00000524255.5 ENST00000523296.1 |
SFTPC
|
surfactant protein C |
chr5_-_151686908 | 2.51 |
ENST00000231061.9
|
SPARC
|
secreted protein acidic and cysteine rich |
chr1_-_160523204 | 2.51 |
ENST00000368055.1
ENST00000368057.8 ENST00000368059.7 |
SLAMF6
|
SLAM family member 6 |
chr19_-_49362376 | 2.49 |
ENST00000601519.5
ENST00000593945.6 ENST00000539846.5 ENST00000596757.1 ENST00000311227.6 |
TEAD2
|
TEA domain transcription factor 2 |
chr19_-_42132391 | 2.41 |
ENST00000528894.8
ENST00000560804.6 ENST00000560558.5 ENST00000560398.5 ENST00000526816.6 ENST00000625670.2 |
POU2F2
|
POU class 2 homeobox 2 |
chr7_+_143132069 | 2.40 |
ENST00000291009.4
|
PIP
|
prolactin induced protein |
chr4_+_54657918 | 2.39 |
ENST00000412167.6
ENST00000288135.6 |
KIT
|
KIT proto-oncogene, receptor tyrosine kinase |
chr1_+_203765168 | 2.39 |
ENST00000367217.5
ENST00000442561.7 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
chr13_+_101452629 | 2.38 |
ENST00000622834.4
ENST00000545560.6 ENST00000376180.8 |
ITGBL1
|
integrin subunit beta like 1 |
chr17_+_79022814 | 2.33 |
ENST00000578229.5
|
C1QTNF1
|
C1q and TNF related 1 |
chr7_-_120857124 | 2.33 |
ENST00000441017.5
ENST00000424710.5 ENST00000433758.5 |
TSPAN12
|
tetraspanin 12 |
chr11_+_847197 | 2.33 |
ENST00000532375.5
ENST00000346501.8 |
TSPAN4
|
tetraspanin 4 |
chr11_+_72216774 | 2.33 |
ENST00000619261.4
ENST00000454954.6 ENST00000541003.5 ENST00000539412.5 ENST00000298223.11 ENST00000536778.5 ENST00000535625.5 ENST00000321324.11 |
FOLR2
|
folate receptor beta |
chr13_-_106535653 | 2.31 |
ENST00000646441.1
|
EFNB2
|
ephrin B2 |
chr1_+_100719734 | 2.31 |
ENST00000370119.8
ENST00000294728.7 ENST00000347652.6 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
chr19_-_41353904 | 2.31 |
ENST00000221930.6
|
TGFB1
|
transforming growth factor beta 1 |
chr6_+_96562548 | 2.30 |
ENST00000541107.5
ENST00000326771.2 |
FHL5
|
four and a half LIM domains 5 |
chr1_-_153609322 | 2.30 |
ENST00000368704.5
ENST00000368705.2 |
S100A16
|
S100 calcium binding protein A16 |
chr17_-_19386785 | 2.30 |
ENST00000497081.6
|
MFAP4
|
microfibril associated protein 4 |
chr17_+_34356472 | 2.28 |
ENST00000225844.7
|
CCL13
|
C-C motif chemokine ligand 13 |
chr19_-_46784733 | 2.28 |
ENST00000593713.1
ENST00000598022.1 ENST00000434726.6 |
SLC1A5
|
solute carrier family 1 member 5 |
chr4_-_99321362 | 2.27 |
ENST00000625860.2
ENST00000305046.13 ENST00000506651.5 |
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide |
chr22_-_30246739 | 2.27 |
ENST00000403987.3
ENST00000249075.4 |
LIF
|
LIF interleukin 6 family cytokine |
chr2_-_207165923 | 2.26 |
ENST00000309446.11
|
KLF7
|
Kruppel like factor 7 |
chr7_-_131556602 | 2.24 |
ENST00000322985.9
ENST00000378555.8 |
PODXL
|
podocalyxin like |
chr19_+_17527250 | 2.23 |
ENST00000599164.6
ENST00000449408.6 ENST00000600871.5 ENST00000599124.1 |
NIBAN3
|
niban apoptosis regulator 3 |
chr11_-_107858777 | 2.23 |
ENST00000525815.6
|
SLC35F2
|
solute carrier family 35 member F2 |
chr5_-_169300782 | 2.22 |
ENST00000332966.8
|
SLIT3
|
slit guidance ligand 3 |
chr5_-_169301098 | 2.21 |
ENST00000519560.6
|
SLIT3
|
slit guidance ligand 3 |
chr11_+_71998892 | 2.20 |
ENST00000393705.8
ENST00000393703.9 ENST00000337131.9 ENST00000620017.4 ENST00000531053.5 ENST00000404792.5 |
IL18BP
|
interleukin 18 binding protein |
chr10_-_72088504 | 2.20 |
ENST00000536168.2
|
SPOCK2
|
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 |
chr1_-_152036984 | 2.18 |
ENST00000271638.3
|
S100A11
|
S100 calcium binding protein A11 |
chr2_-_85663393 | 2.18 |
ENST00000494165.1
|
SFTPB
|
surfactant protein B |
chr7_-_78771265 | 2.17 |
ENST00000630991.2
ENST00000629359.2 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr1_+_32362537 | 2.17 |
ENST00000373534.4
|
TSSK3
|
testis specific serine kinase 3 |
chr6_-_33080710 | 2.16 |
ENST00000419277.5
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr16_-_21857657 | 2.14 |
ENST00000341400.11
ENST00000518761.8 ENST00000682606.1 |
NPIPB4
|
nuclear pore complex interacting protein family member B4 |
chr12_-_10098977 | 2.13 |
ENST00000315330.8
ENST00000457018.6 |
CLEC1A
|
C-type lectin domain family 1 member A |
chr11_-_72674394 | 2.13 |
ENST00000418754.6
ENST00000334456.10 ENST00000542969.2 |
PDE2A
|
phosphodiesterase 2A |
chr3_-_64687613 | 2.12 |
ENST00000295903.8
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif 9 |
chr6_+_29550407 | 2.12 |
ENST00000641137.1
|
OR2I1P
|
olfactory receptor family 2 subfamily I member 1 pseudogene |
chr19_-_42528380 | 2.11 |
ENST00000403461.5
ENST00000352591.9 ENST00000358394.7 ENST00000403444.7 ENST00000161559.11 ENST00000599389.1 |
CEACAM1
|
CEA cell adhesion molecule 1 |
chr9_-_114387973 | 2.11 |
ENST00000374088.8
|
AKNA
|
AT-hook transcription factor |
chrX_+_48683763 | 2.11 |
ENST00000376701.5
|
WAS
|
WASP actin nucleation promoting factor |
chr8_+_22161655 | 2.11 |
ENST00000318561.7
|
SFTPC
|
surfactant protein C |
chr12_-_108598036 | 2.11 |
ENST00000392806.4
ENST00000547567.1 |
TMEM119
|
transmembrane protein 119 |
chr9_+_109780312 | 2.10 |
ENST00000483909.5
ENST00000413420.5 ENST00000302798.7 |
PALM2AKAP2
|
PALM2 and AKAP2 fusion |
chr10_+_80131660 | 2.09 |
ENST00000372270.6
|
PLAC9
|
placenta associated 9 |
chr2_+_118942188 | 2.08 |
ENST00000327097.5
|
MARCO
|
macrophage receptor with collagenous structure |
chr2_-_55923775 | 2.07 |
ENST00000438672.5
ENST00000355426.8 ENST00000440439.5 ENST00000429909.5 ENST00000424207.5 ENST00000452337.5 ENST00000439193.5 ENST00000421664.1 |
EFEMP1
|
EGF containing fibulin extracellular matrix protein 1 |
chrX_+_38561530 | 2.07 |
ENST00000378482.7
ENST00000286824.6 |
TSPAN7
|
tetraspanin 7 |
chr19_-_11577632 | 2.05 |
ENST00000590420.1
ENST00000648477.1 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr22_+_22395005 | 2.04 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr19_-_46661132 | 2.01 |
ENST00000410105.2
ENST00000391916.7 |
DACT3
|
dishevelled binding antagonist of beta catenin 3 |
chr8_-_118951876 | 2.01 |
ENST00000297350.9
|
TNFRSF11B
|
TNF receptor superfamily member 11b |
chr1_-_44017296 | 2.01 |
ENST00000357730.6
ENST00000360584.6 ENST00000528803.1 |
SLC6A9
|
solute carrier family 6 member 9 |
chr10_-_79949098 | 1.99 |
ENST00000372292.8
|
SFTPD
|
surfactant protein D |
chr2_+_231710417 | 1.99 |
ENST00000412128.1
|
PTMA
|
prothymosin alpha |
chr14_-_106389858 | 1.98 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr11_+_35189869 | 1.98 |
ENST00000525688.5
ENST00000278385.10 ENST00000533222.5 |
CD44
|
CD44 molecule (Indian blood group) |
chr6_-_33080767 | 1.97 |
ENST00000453337.1
ENST00000417724.1 |
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr11_+_57598184 | 1.97 |
ENST00000677625.1
ENST00000676670.1 |
SERPING1
|
serpin family G member 1 |
chr9_+_133534697 | 1.96 |
ENST00000651351.2
|
ADAMTSL2
|
ADAMTS like 2 |
chr19_+_16888991 | 1.95 |
ENST00000248076.4
|
F2RL3
|
F2R like thrombin or trypsin receptor 3 |
chr19_-_43781249 | 1.94 |
ENST00000615047.4
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr12_-_10098940 | 1.93 |
ENST00000420265.2
|
CLEC1A
|
C-type lectin domain family 1 member A |
chr16_+_56961942 | 1.92 |
ENST00000200676.8
ENST00000566128.1 |
CETP
|
cholesteryl ester transfer protein |
chr13_+_30735523 | 1.92 |
ENST00000380490.5
|
ALOX5AP
|
arachidonate 5-lipoxygenase activating protein |
chr4_+_73740541 | 1.92 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
chr10_-_95290992 | 1.89 |
ENST00000329399.7
|
PDLIM1
|
PDZ and LIM domain 1 |
chr12_+_6951345 | 1.89 |
ENST00000318974.14
ENST00000541698.5 ENST00000542462.1 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
chr12_-_11269696 | 1.87 |
ENST00000381842.7
|
PRB3
|
proline rich protein BstNI subfamily 3 |
chr7_+_142320677 | 1.86 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr22_+_36913620 | 1.86 |
ENST00000403662.8
ENST00000262825.9 |
CSF2RB
|
colony stimulating factor 2 receptor subunit beta |
chr2_+_27078598 | 1.86 |
ENST00000380320.9
|
EMILIN1
|
elastin microfibril interfacer 1 |
chr17_+_79024142 | 1.86 |
ENST00000579760.6
ENST00000339142.6 |
C1QTNF1
|
C1q and TNF related 1 |
chr12_-_7695752 | 1.82 |
ENST00000329913.4
|
GDF3
|
growth differentiation factor 3 |
chr22_-_31107517 | 1.82 |
ENST00000400299.6
ENST00000611680.1 |
SELENOM
|
selenoprotein M |
chr15_-_74433942 | 1.78 |
ENST00000543145.6
ENST00000261918.9 |
SEMA7A
|
semaphorin 7A (John Milton Hagen blood group) |
chr20_-_50636887 | 1.78 |
ENST00000045083.6
|
RIPOR3
|
RIPOR family member 3 |
chr9_+_70043840 | 1.78 |
ENST00000377182.5
|
MAMDC2
|
MAM domain containing 2 |
chr22_+_31082860 | 1.78 |
ENST00000619644.4
|
SMTN
|
smoothelin |
chr16_-_29505820 | 1.78 |
ENST00000550665.5
|
NPIPB12
|
nuclear pore complex interacting protein family member B12 |
chr11_+_13962676 | 1.78 |
ENST00000576479.4
|
SPON1
|
spondin 1 |
chr16_+_3065297 | 1.78 |
ENST00000325568.9
|
IL32
|
interleukin 32 |
chr1_-_153565535 | 1.78 |
ENST00000368707.5
|
S100A2
|
S100 calcium binding protein A2 |
chr16_+_3065311 | 1.76 |
ENST00000534507.5
ENST00000613483.4 ENST00000531965.5 ENST00000396887.7 |
IL32
|
interleukin 32 |
chr16_+_22513523 | 1.76 |
ENST00000538606.5
ENST00000451409.5 ENST00000424340.5 ENST00000517539.5 ENST00000528249.5 |
NPIPB5
|
nuclear pore complex interacting protein family member B5 |
chr12_-_11310420 | 1.75 |
ENST00000621732.4
ENST00000445719.2 ENST00000279575.7 |
PRB4
|
proline rich protein BstNI subfamily 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.2 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
1.7 | 10.1 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
1.5 | 4.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
1.4 | 4.1 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
1.3 | 9.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
1.3 | 3.9 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.2 | 3.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.2 | 4.8 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
1.1 | 6.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.1 | 2.1 | GO:0001300 | chronological cell aging(GO:0001300) |
1.0 | 5.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.0 | 3.0 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.9 | 2.8 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.9 | 6.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.9 | 2.6 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.8 | 5.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 4.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.8 | 3.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.8 | 3.3 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.8 | 138.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 2.4 | GO:0070662 | erythropoietin-mediated signaling pathway(GO:0038162) mast cell proliferation(GO:0070662) |
0.8 | 1.5 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.8 | 2.3 | GO:1905237 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) response to cyclosporin A(GO:1905237) |
0.8 | 3.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 3.6 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.7 | 0.7 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.7 | 2.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.7 | 2.1 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.7 | 5.6 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.7 | 4.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.7 | 13.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.7 | 2.0 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.6 | 4.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.6 | 11.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.6 | 4.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 7.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 2.4 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.6 | 13.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 1.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.6 | 2.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 2.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 2.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.5 | 1.6 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.5 | 1.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.5 | 1.6 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.5 | 2.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.5 | 1.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 2.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 2.6 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 1.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 2.0 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.5 | 1.4 | GO:0098736 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.5 | 0.9 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.4 | 1.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 3.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 1.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 | 3.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.4 | 1.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 1.7 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.4 | 2.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 | 1.6 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.4 | 2.8 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.4 | 2.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.4 | 1.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.4 | 1.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 6.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 1.5 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.4 | 1.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.4 | 1.5 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.4 | 1.8 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 2.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 1.1 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.4 | 2.5 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.4 | 2.1 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.4 | 1.4 | GO:0042335 | cuticle development(GO:0042335) |
0.3 | 1.4 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 0.7 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.3 | 1.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.3 | 1.0 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.3 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 2.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 2.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 4.6 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.3 | 1.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.3 | 4.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 3.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.3 | 0.9 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.9 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 1.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.3 | 2.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 6.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 1.2 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.3 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.8 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.3 | 1.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 1.4 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.3 | 1.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.9 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.3 | 1.6 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 0.8 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.3 | 0.8 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.3 | 0.3 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.3 | 0.8 | GO:2000407 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 0.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 1.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.3 | 1.5 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.3 | 0.8 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.3 | 2.8 | GO:2000795 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 1.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.2 | 1.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 2.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.2 | 1.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 1.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 2.7 | GO:0010269 | response to selenium ion(GO:0010269) |
0.2 | 3.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 4.4 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 1.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.2 | 1.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.9 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.2 | 1.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 2.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 3.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.7 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 1.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 44.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.4 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 1.4 | GO:0045653 | negative regulation of MHC class II biosynthetic process(GO:0045347) negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 2.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 2.5 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 3.3 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 2.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.6 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.2 | 3.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 3.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 0.9 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.2 | 1.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 1.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.5 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 2.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 1.9 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 0.7 | GO:0002840 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) |
0.2 | 0.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.2 | 1.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 0.8 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.2 | 1.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 1.3 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.5 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 1.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 1.1 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 2.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.0 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.2 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 2.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 3.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.2 | 0.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.1 | 18.8 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 3.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.7 | GO:0002606 | regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 1.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 2.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 1.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 0.8 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of T cell migration(GO:2000405) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.1 | 1.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.4 | GO:1903463 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) regulation of mitotic cell cycle DNA replication(GO:1903463) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 1.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 1.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 1.3 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 2.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.4 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.1 | 3.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.1 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.1 | 0.5 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.6 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 1.5 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 1.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 2.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 1.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 4.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 1.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 2.9 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.6 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 2.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 2.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.4 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.1 | 1.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 1.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.7 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 1.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 2.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 1.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 1.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 2.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 1.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.4 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 2.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 2.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 1.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 3.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.2 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.7 | GO:1901297 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 5.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.5 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 2.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.5 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0014011 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.1 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 1.8 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 2.1 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 2.8 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.4 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.1 | 2.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 1.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 1.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 4.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 2.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 2.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 1.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 1.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 1.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 1.3 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0097698 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
0.0 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 3.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 1.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.3 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 1.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 1.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) axial mesoderm development(GO:0048318) |
0.0 | 0.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 1.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.3 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.0 | 0.6 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.1 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.0 | 0.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 1.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 4.6 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 1.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 1.0 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 1.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 1.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 1.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.2 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.0 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.9 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 1.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.8 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.7 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:1905205 | regulation of connective tissue replacement(GO:1905203) positive regulation of connective tissue replacement(GO:1905205) |
0.0 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.4 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.2 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 1.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 1.1 | GO:2000181 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.9 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 1.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.0 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.0 | 7.6 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 14.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 3.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.9 | 2.8 | GO:0001534 | radial spoke(GO:0001534) |
0.9 | 53.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.8 | 16.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.8 | 2.3 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.7 | 2.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.7 | 3.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.6 | 1.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 1.9 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.6 | 3.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.5 | 1.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.5 | 5.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
0.4 | 6.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.4 | 2.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 7.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.4 | 2.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 1.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 1.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 5.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 2.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.6 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 4.9 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.7 | GO:1990879 | CST complex(GO:1990879) |
0.2 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 0.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.2 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 5.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.2 | 5.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 3.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 7.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 21.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 2.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 3.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 8.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 2.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 13.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 2.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 2.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 8.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 9.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.8 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 12.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 10.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0097409 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
0.1 | 0.9 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 3.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 3.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 5.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 6.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 1.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 76.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 2.0 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 4.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 2.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 20.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 9.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 1.3 | GO:0005903 | brush border(GO:0005903) |
0.0 | 1.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 4.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 22.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 2.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 3.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 2.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 6.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 4.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 1.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 3.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 2.4 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.3 | GO:0097451 | astrocyte end-foot(GO:0097450) glial limiting end-foot(GO:0097451) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 2.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 40.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.1 | 4.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.9 | 5.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.9 | 2.6 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.8 | 4.2 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.8 | 14.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.8 | 3.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.8 | 5.6 | GO:0042806 | fucose binding(GO:0042806) |
0.8 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 54.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 2.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.7 | 2.8 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.7 | 1.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.7 | 3.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.6 | 1.9 | GO:0017129 | triglyceride binding(GO:0017129) |
0.6 | 1.9 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.6 | 129.7 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 1.9 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.6 | 2.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.6 | 3.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 4.8 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 4.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.5 | 2.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.5 | 2.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.5 | 1.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.5 | 4.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 1.8 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 6.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 10.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 3.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.4 | 4.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 2.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.9 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.4 | 1.1 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.4 | 1.5 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.3 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.3 | 2.7 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 3.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 2.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.6 | GO:0086020 | gap junction hemi-channel activity(GO:0055077) gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.3 | 9.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 4.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 4.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 2.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 2.1 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 2.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.8 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 1.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 2.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 1.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.2 | 6.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 2.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 9.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 1.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 2.9 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 2.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 2.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.7 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.9 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.2 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 7.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.0 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.2 | 4.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 3.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 1.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 3.1 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.1 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 1.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 3.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.1 | 0.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.1 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 2.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 1.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.7 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.5 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 2.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 4.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.1 | 0.6 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 3.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 8.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 3.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 2.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 5.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 2.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.8 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 12.2 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0043273 | CTPase activity(GO:0043273) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 5.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.1 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.2 | GO:0047750 | C-8 sterol isomerase activity(GO:0000247) cholestenol delta-isomerase activity(GO:0047750) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0044714 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.0 | 8.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 2.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 1.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 1.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 1.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 2.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 1.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 15.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 2.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 1.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 9.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 5.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 1.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.9 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 4.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 2.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 4.9 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 1.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 18.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 11.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 4.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 29.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 7.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 6.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 10.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 6.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 11.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 3.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 33.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 4.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 4.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 10.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 10.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 5.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 7.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 18.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 2.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 3.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.6 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 3.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 6.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 5.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 26.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.6 | 5.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 0.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 4.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 4.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 5.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 5.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.0 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 11.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 4.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 3.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 4.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 17.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 5.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 3.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 5.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 7.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 6.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 4.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 7.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 3.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 2.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 2.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 2.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 3.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 3.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 5.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 4.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 2.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |